Close Menu

NEW YORK – Geisinger Health System's Steele Institute for Health Innovation is teaming with Israeli healthcare software company Medial EarlySign to develop machine-learning technologies for identification of patients at risk of "high-burden" and chronic diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.